MedPath

STEPHEN GERALD CHOI

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:1
Completed:2

Trial Phases

1 Phases

Phase 4:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 4
1 (100.0%)

Cognitive Changes After Major Joint Replacement - Full Trial (Cognigram 2)

Active, not recruiting
Conditions
Delirium
Cognitive Decline
Autoimmune Diseases
Cognitive Impairment
Cognitive Change
Postoperative Cognitive Dysfunction
Working Memory
Inflammation
Mild Cognitive Impairment
First Posted Date
2017-05-10
Last Posted Date
2024-01-11
Lead Sponsor
Dr. Stephen Choi
Target Recruit Count
505
Registration Number
NCT03147937
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

Cognitive Changes After Major Joint Replacement

Completed
Conditions
Delirium
Cognitive Deficit
Postoperative Cognitive Dysfunction
Mild Cognitive Impairment
Cognitive Change
Working Memory
First Posted Date
2016-11-16
Last Posted Date
2017-05-10
Lead Sponsor
Dr. Stephen Choi
Target Recruit Count
90
Registration Number
NCT02964221

The Effects of Dexamethasone on Low Dose Interscalene Brachial Plexus Block

Phase 4
Completed
Conditions
Nerve Block
Shoulder Surgery
Interventions
First Posted Date
2014-12-23
Last Posted Date
2020-07-15
Lead Sponsor
Dr. Stephen Choi
Target Recruit Count
182
Registration Number
NCT02322242
Locations
🇨🇦

Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.